Histolix, Inc.

United States - Sacramento

• 03/07/2023
• Unknown
• $3,200,000

Histolix has developed a novel point-of-care histopathology solution enabling direct to digital diagnosis of tissue in surgery suites and at the clinical point-of-care, delivering high quality digitized images to permit rapid diagnosis. This can eliminate the need for time consuming and expensive histologic procedure required to produce paraffin sections on glass slides. It could enable same-day patient diagnosis and potentially reduce the requirement of additional surgical procedures, providing direct-to-digital image, slide free pathology designed to be created within five minutes of tissue presentation versus the traditional eight hours to days of required processing for whole slide imaging.

Led by longtime healthcare industry executives with multiple commercial exits in coordination with on ongoing, pioneering research by well-known University of California, Davis pathology researchers, Histolix provides the disruption needed for the growth of digital pathology across multiple use cases. With millions of grant and private investment dollars already deployed, Histolix technology is providing rapid, cost-effective, non-destructive intrinsically digital, slide-free tissue histology without compromising the quality of downstream molecular testing.

Related People

Rob RoyeaFounder

United States - San Francisco Bay Area

Awarded the Top 40 Healthcare Transformer honor by MM&M Magazine, Rob is a Senior Operational, Sales, and Marketing executive with demonstrated success at creating and executing strategies necessary to grow sophisticated medical technology and software companies. Has proven visionary expertise in facilitating market expansion through merger, acquisition, strategic partnership, and corporate branding, resulting in sustainable revenue and EBITDA gains. Is an established leader in the healthcare market, from start-up phase environments to demonstrated P & L responsibilities over $550 million. Rob's work is published in Computer Methods and Programs in Biomedicine, and he holds multiple Design and Invention patents with additional patents pending.

Specialties: Strategic Business, Sales & Market Planning
 Global Budgeting and P & L Implementation
 Emerging Market Identification & Expansion
 Global Business Operations Management
 Direct and Distribution Sales Implementation
 Marketing and Corporate branding
 Sales and Marketing leadership
 Strategic Acquisition Identification/Execution

LinkedIn https://www.linkedin.com/in/robroyea/